Mumbai/ New Delhi:
The Supreme Court today rejected Sushant Singh Rajput’s sister Priyanka Singh’s request to scrap a Mumbai Police FIR against her for allegedly faking a prescription to help the actor access banned anxiety medication.
Last month, the Bombay High Court had endorsed the case against Priyanka Singh but had dismissed another against Sushant Singh Rajput’s other sister Mitu Singh. Both cases were based on actor Rhea Chakraborty’s complaint. The Supreme Court refused to cancel the case against Priyanka Singh.
The sisters were accused of forgery and violation of the NDPS (Narcotic Drugs and Psychotropic Substances) Act based on complaints by actor Rhea Chakraborty, who dated Sushant Singh Rajput and is being investigated by multiple agencies after his family accused her of having a role in his death last June.
The High Court said the CBI investigation against Priyanka Singh would continue. “There is prima facie case found against Priyanka Singh and there should not be any impediment against investigation against her,” the judges said.
Sushant Singh Rajput, 34, a popular Bollywood star, was found dead in his apartment in Mumbai on June 14.
Rhea Chakraborty filed a case against his sisters Priyanka Singh and Meetu Singh based on WhatsApp texts between the actor and his sister on June 8, 2020 — six days before he was found dead.
The chats indicated that Priyanka Singh had advised her brother to take three medicines — Librium, Mexito and Lonazep — which are prescribed for depression and anxiety but cannot be bought over the counter.
Rhea Chakraborty alleges that Priyanka Singh sent her brother a fabricated prescription on WhatsApp to help Sushant Rajput access medicines banned under the Narcotic Drugs and Psychotropic Substances Act.
She also pointed out that the chats indicated that contrary to their claims, his family was aware of his mental health problems.
Rhea Chakraborty spent 28 days in jail in September on charges of arranging drugs for Sushant Singh Rajput.